Feng Yang

Years Active: 2022-2024
Publications (10 Years): 5

This page only lists publications with an associated author ORCID identifier.

Publications

Anan Li, Shijiang Wang, Jiangbo Nie, Shining Xiao, Xinsheng Xie, Yu Zhang, Weilai Tong, Geliang Yao, Ning Liu, Fan Dan, Zhiguo Shu, Jia-Ming Liu, Zhili Liu, Feng Yang
USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway. Cell death & disease 15 (3) (2024)
Anan Li, Shijiang Wang, Jiangbo Nie, Shining Xiao, Xinsheng Xie, Yu Zhang, Weilai Tong, Geliang Yao, Ning Liu, Fan Dan, Zhiguo Shu, Jia-Ming Liu, Zhili Liu, Feng Yang
USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway. Cell death & disease 15 (3) (2024)
Shining Xiao, Yu Zhang, Shijiang Wang, Jiaming Liu, Fan Dan, Feng Yang, Shue Hong, Ning Liu, Yujia Zeng, Ke Huang, Xinsheng Xie, Yanxin Zhong, Zhili Liu
The Syvn1 inhibits neuronal cell ferroptosis by activating Stat3/Gpx4 axis in rat with spinal cord injury. Cell proliferation (2024)
Anan Li, Shijiang Wang, Jiangbo Nie, Shining Xiao, Xinsheng Xie, Yu Zhang, Weilai Tong, Geliang Yao, Ning Liu, Fan Dan, Zhiguo Shu, Jia-Ming Liu, Zhili Liu, Feng Yang
USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway. Cell death & disease 15 (3) (2024)
Feng Yang, Yangyang Liu, Jun Xiao, Bo Li, Yajun Chen, Anpei Hu, Jin Zeng, Zhi Li Liu, Hucheng Liu
Circ-CTNNB1 drives aerobic glycolysis and osteosarcoma progression via m6A modification through interacting with RBM15. Cell proliferation (2022)

Feng Yang.css-eqlu8i{font-size:small;padding-left:4px;}